Epigenetic mechanisms in breast cancer therapy and resistance

L Garcia-Martinez, Y Zhang, Y Nakata, HL Chan… - Nature …, 2021 - nature.com
The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this
pathway represent the main treatment modality. Endocrine therapy has proven successful in …

The SWI/SNF complex in cancer—biology, biomarkers and therapy

P Mittal, CWM Roberts - Nature reviews Clinical oncology, 2020 - nature.com
Cancer genome-sequencing studies have revealed a remarkably high prevalence of
mutations in genes encoding subunits of the SWI/SNF chromatin-remodelling complexes …

The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability

G Milazzo, D Mercatelli, G Di Muzio, L Triboli… - Genes, 2020 - mdpi.com
Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by
removing acetyl groups from histones and other protein regulatory factors, with functional …

Targeting ARID1A mutations in cancer

J Mullen, S Kato, JK Sicklick, R Kurzrock - Cancer treatment reviews, 2021 - Elsevier
Genes encoding SWI/SNF chromatin remodeling complex subunits are collectively mutated
in approximately 20% of human cancers. ARID1A is a SWI/SNF subunit gene whose protein …

[HTML][HTML] Genomic and transcriptomic characterization of natural killer T cell lymphoma

J Xiong, BW Cui, N Wang, YT Dai, H Zhang, CF Wang… - Cancer Cell, 2020 - cell.com
Natural killer/T cell lymphoma (NKTCL) is an aggressive and heterogeneous entity of non-
Hodgkin lymphoma, strongly associated with Epstein-Barr virus (EBV) infection. To identify …

Epigenetic therapy for ovarian cancer: promise and progress

S Moufarrij, M Dandapani, E Arthofer, S Gomez… - Clinical …, 2019 - Springer
Ovarian cancer is the deadliest gynecologic malignancy, with a 5-year survival rate of
approximately 47%, a number that has remained constant over the past two decades. Early …

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation

YH Lo, KS Kolahi, Y Du, CY Chang, A Krokhotin, A Nair… - Cancer discovery, 2021 - AACR
Mutations in ARID1A rank among the most common molecular aberrations in human cancer.
However, oncogenic consequences of ARID1A mutation in human cells remain poorly …

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

M Wanior, A Krämer, S Knapp, AC Joerger - Oncogene, 2021 - nature.com
Multi-subunit ATPase-dependent chromatin remodelling complexes SWI/SNF
(switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene …

Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer

AP Bracken, GL Brien, CP Verrijzer - Genes & development, 2019 - genesdev.cshlp.org
Abstract Changes in chromatin structure mediated by ATP-dependent nucleosome
remodelers and histone modifying enzymes are integral to the process of gene regulation …